OTCMKTS:PCTL
Biotech

PCT Ltd (OTCMKTS:PCTL) Running On COVID-19 Opportunity

The only reason to trade penny stocks is for the explosive moves they can make. If a penny stock doesn’t have triple-digit or 10-bagger potential, there’s no reason to really be owning them. We at Insider Financial understand this and we spend our time hunting for penny stocks that can make big moves. One such stock is PCT Ltd (OTCMKTS:PCTL).

We alerted our subscribers to the stock back on March 3rd when the stock was trading at just $.02 a share. Subscribers are now sitting on gains of over 300%. This is the key with trading stocks. Identify the momentum before it happens. After it’s too late and you end up holding the bag like a sucker, which is what happens to most investors in penny stocks.

OTCMKTS:PCTL Price Analysis

The company is on course to register robust revenue growth given the unprecedented growth for the company’s technologies and solutions. It does not come as a surprise that the stock is up by more than 300% for the year, outperforming the S&P 500, which is down by more than 15%. As it stands, PCT Ltd is one of the few companies that is surging as the COVID-19 pandemic continues to rattle various sectors of the global economy.

A spike from the $0.07 level leaves the stock trading close to a key resistance level at $0.09. A rally followed by a close above the $0.09 level should affirm PCT Ltd breakout credentials paving the way for the stock to continue powering higher.

PTCL Daily Report

The 0.04 level is the immediate support level from where the stock remains well anchored to continue edging high. Above the critical support level, PCT LTD remains bullish.

About OTCMKTS:PCTL

PCT Ltd is a diversified holding company that develops, acquires, and distributes environmentally safe disinfecting cleaning and tracking technologies. Its products continue to elicit strong demand, especially in hospitals where there is a need for increased disinfection amidst the coronavirus pandemic.

U.K Distribution Agreement

OTCMKTS:PCTL is exploding in the market, having emerged that its financials are poised to improve significantly thanks to the perfect business opportunity triggered by the coronavirus pandemic. The company is fresh from signing an exclusive trading partnership /distributor agreement in the U.K

The agreement with U.K National Health Service Company paves the way for PCT Ltd to start distributing its PCT technology to NHS hospital Trust as part of an effort of combating the coronavirus.  Under the terms of the agreement, the company is to distribute its PCT technology to 233 Trusts made up of over 600 hospitals. In addition, the company will be able to distribute its solutions to approximately 14,000 Care Homes in the U.K

“This arrangement will introduce our system to thousands of hospitals and healthcare facilities. At the same time, the reality of the current healthcare crisis, both domestically and abroad, is sobering. We’re thrilled to be able to grow our business but nevertheless remain focused on our core mission, which from day one has always been helping people,” says PCT CEO Gary Grieco.

Increasing Purchase Orders

In addition to international expansion, OTCMKTS:PCTL continues to expand and strengthen its operations in the U.S, where it generates a good chunk of its revenues. The company has especially focused its resources on the New York market, heavily hit by the COVID-19 pandemic.

The company has already secured an additional purchase order for its Annihilyzer Infection Control Systems. The order comes from a large New York City Hospital with a bed count of about 1,000. PCT LTD has already signed Three Purchase Orders for its infection control system, affirming the strong demand in the market.

The U.K distribution agreement backed by growing Purchase orders in the U.S should go a long way in strengthening PCT LTD financials. PCT LTD is fresh from reporting a 435% increase in revenues for its third quarter that came in at $220,033. The revenue increase is attributed to an increase in volume for fluids sold as well as equipment sales and recurring leased income

Robust revenue growth in Q3 is still not indicative of the significant growth that PCT is experiencing at the back of massive opportunities created by the coronavirus. The company’s sales pipeline for equipment, as well as fluids, continue to accelerate at an impressive rate pointing to a record-breaking year in terms of revenues and earnings growth.

Bottom Line

OTCMKTS:PCTL still appears to be setting up to continue running higher, given the tremendous growth the company continues to experience. The demand for the company’s disinfection technologies continues to increase every day. Likewise, the company is increasingly signing purchase orders with hospitals in the U.S and the U.K. Overall, OTCMKTS:PCTL looks set to continue powering higher, given the robust growth the company core business continues to experience fuelled by the COVID-19 pandemic.

Good luck to all (except the shorts)!

We will be updating our subscribers on the hottest penny stocks. For breaking updates, sign up today!

Disclosure: We have no position in OTCMKTS:PCTL and have not been compensated for this article.

Image by Engin Akyurt from Pixabay

GET NOTIFIED
Sign up for our next MicroCap Runner ahead of the crowd!
We hate spam. No Hidden Fees. Unsubscribe Anytime.
PCT Ltd (OTCMKTS:PCTL) Running On COVID-19 Opportunity
Click to comment
To Top